Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Pharma Perspectives

EISAI

Eisai’s Lenvima wins European liver cancer indication

EC green-lights the RTK inhibitor as a first-line treatment

- PMLiVE

Ipsen’s liver cancer treatment clears phase III trial

Cabometyx on track for new liver cancer indication

Bayer symbol

EMA clears Bayer’s Stivarga for liver cancer

The multikinase inhibitor will treat patients with HCC

Bayer symbol

Bayer nets speedy US review for regorafenib in liver cancer

Priority review in HCC boosts hopes for rejuvenation of Stivarga to combat declining sales

- PMLiVE

Pharma Perspectives with the HCC: Malik Akhtar on the pitching process

Bayer's category lead for agency services gives a pharma view

- PMLiVE

Pharma Perspectives with the HCC: Ben Davies on the pitching process

Havas Health's European CEO gives an agency view

- PMLiVE

Introducing pharma perspectives

Matt de Gruchy outlines the HCC's forthcoming collaboration with PME

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links